Clinical Trials Directory

Trials / Completed

CompletedNCT06168500

Narrow Implants Vs Standard Implants With Simultaneous GBR

Narrow Diameter Implants Versus Standard Diameter Implants With Simultaneous Bone Regeneration For The Treatment Of Atrophic Posterior Area

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Universitat Internacional de Catalunya · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

NDI represent an advisable treatment option when the mesio-distal space is compromised. In a recent retrospective study with a follow-up of 8 years in which they wanted to evaluate the long-term survival, complications, peri-implant conditions, marginal bone loss, and patient satisfaction of fixed dental prostheses supported by NDI in the posterior area. They observe a survival rate of 97% and absence of prosthetic complications after the study period time. More recently, Souza et al. performed a prospective randomized split mouth study with 3 years follow-up with the aim of comparing marginal bone level, implant survival and success rates and prosthesis success rates of NDI and SDI placed in the posterior area of the mandible to support single prosthesis. They observed an implant survival rate of 100% for both groups at 1 and 3 years. The prosthesis success rate at 1 and 3 years was of 95.4% and 100%, respectively. NDI present a high survival rate on the evaluated studies. Therefore, the aim of the first study is to compare the patient related outcomes, implants and prostheses success and survival rates of pure titanium NDI versus SDI with simultaneous bone regeneration in narrow alveolar ridges at posterior areas of the maxilla and the mandible.

Conditions

Interventions

TypeNameDescription
PROCEDURETest group3.0mm diameter implant
PROCEDUREControl group4.0 diameter implant + guided bone regeneration

Timeline

Start date
2021-07-12
Primary completion
2024-12-28
Completion
2025-12-28
First posted
2023-12-13
Last updated
2026-03-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06168500. Inclusion in this directory is not an endorsement.